Back to News
investment

SCZ ETF: There's Other, Better, Cheaper Options

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
The iShares MSCI EAFE Small-Cap ETF (SCZ) received a "Hold" rating due to its 0.40% expense ratio, which undercuts long-term returns compared to cheaper alternatives like VSS and SCHC. SCZ offers broad diversification with 2,010 holdings and strong liquidity but lags its benchmark and lower-cost peers despite a 32.10% NAV return in 2025 and favorable macroeconomic conditions. Japan’s 35% weighting in SCZ introduces significant concentration risk, potentially exposing investors to regional volatility and underperformance relative to more balanced funds. Unhedged currency exposure poses additional risks for USD-based investors, compounding fee drag and reducing net returns over time. Analysts highlight better-performing alternatives, emphasizing cost efficiency and reduced regional concentration as key factors for small-cap international ETF selection.
AI Audio Summary
0:00 / 0:00
Click to play
Gemini_Generated_Image_5thz005thz005thz.png
Quantum News · Media Library

Nikola Lapenna191 FollowersFollow5ShareSavePlay(11min)CommentsSummaryI rate iShares MSCI EAFE Small-Cap ETF (SCZ) a Hold, citing its high 0.40% expense ratio versus cheaper passive alternatives.SCZ offers broad diversification with 2,010 holdings and strong liquidity, but its fee structure erodes long-term returns compared to VSS and SCHC.Despite a robust 32.10% NAV return in 2025 and favorable macro tailwinds, SCZ's performance lags both its benchmark and lower-cost peers.Japan's 35% weighting introduces concentration risk, while unhedged currency exposure and fee drag remain key risks for USD-based investors. Richard Drury/DigitalVision via Getty Images SCZ Overview The iShares MSCI EAFE Small-Cap ETF (SCZ) is a passively managed exchange-traded fund (also known as an ETF) that invests in small-capitalization equities from developed markets outside the United States and Canada. BlackRock launchedThis article was written byNikola Lapenna191 FollowersFollowWith over three years of finance and consulting experience, Nikola is laser focused on finding value in North American public equities and ETF's. His professional experience includes corporate credit risk analysis, consulting for government entities, and venture capital analysis in the med-tech space. More recently, Nikola has helped investors narrow down better options for ETF's - every asset manager seems to have similar offerings these days. Nikola is not a licensed financial advisor and nothing in his commentary here on Seeking Alpha should be regarded as advice. All of his opinions are his own, and not on behalf of any other entities.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read Original

Tags

quantum-investment

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.